Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,totalAssets,commonStock,retainedEarnings,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,accountsPayable,otherLiab,otherCurrentAssets,otherCurrentLiab,changeToLiabilities,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,repurchaseOfStock,totalCashFromOperatingActivities,changeToAccountReceivables,WC,language,region,quoteType,triggerable,quoteSourceName,exchange,currency,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,dividendDate,marketState,market,shortName,exchangeDataDelayedBy,esgPopulated,tradeable,priceHint,regularMarketChangePercent,regularMarketDayRange,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry,address2
t0,DGEN,1716000.0,0,,,76000,,76000,,245000,77000,77000,168000,,,,,0,263000,186000,18000,-1000,,76000,76000,230638000.0,124000.0,1716000.0,1840000.0,39000.0,-228423000.0,-538000.0,1586000.0,23000.0,99000.0,1586000.0,403000.0,26000.0,228000.0,186000.0,25000.0,87000.0,,,,-2000,-40000,34000,-60000,-40000,-19000,-127000,129000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,0.0019,1629816724,0.0,0.0019,0.0019,0.0019,750,0.0019,0.0,0.0,0,0,finmb_27483,Other OTC,Deltagen Inc.,USD,25808,4637,0.0018000001,18.000002,1.0E-4 - 0.02,-0.018099999,-0.905,0.0001,0.02,1180569600,REGULAR,us_market,DELTAGEN INC,0,False,False,4,0.0,0.0019 - 0.0019,0.053,0.0024194445,-0.00051944447,-0.21469575,0.005757042,-0.0038570422,-0.66996944,3068652,0.035849057,15,America/New_York,EDT,-14400000,-406.35,,,0.02,0.0001,0.0024,0.0058,25.81k,4.64k,,,,,,,,,,,,0.89%,,,,504.61%,"May 30, 2007","May 16, 2007",,,"Dec 30, 2015","Dec 30, 2014",-5.97%,-5.97%,-1.58%,-2.72%,770k,,,766k,,-46k,,,23k,0,25k,1.46,1.45,0.05,24k,66.25k,Value,94403,Healthcare,"Deltagen, Inc. provides drug discovery tools and services to the biopharmaceutical industry and to the academic research community in the United States. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was founded in 1997 and is headquartered in San Mateo, California.",San Mateo,650-345-7601,CA,1167523200,United States,http://www.deltagen.com,86400,1900 South Norfolk Street,Medical Instruments & Supplies,Suite 105
t-1,DGEN,1680000.0,0,,,-92000,,-92000,,76000,-91000,-91000,167000,,,,,0,78000,169000,2000,-1000,,-92000,-92000,230638000.0,91000.0,1680000.0,1771000.0,39000.0,-228499000.0,-498000.0,1586000.0,83000.0,92000.0,1586000.0,402000.0,26000.0,159000.0,59000.0,,89000.0,-1000.0,,,-157000,-40000,6000,-153000,-40000,-154000,89000,67000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,0.0019,1629816724,0.0,0.0019,0.0019,0.0019,750,0.0019,0.0,0.0,0,0,finmb_27483,Other OTC,Deltagen Inc.,USD,25808,4637,0.0018000001,18.000002,1.0E-4 - 0.02,-0.018099999,-0.905,0.0001,0.02,1180569600,REGULAR,us_market,DELTAGEN INC,0,False,False,4,0.0,0.0019 - 0.0019,0.053,0.0024194445,-0.00051944447,-0.21469575,0.005757042,-0.0038570422,-0.66996944,3068652,0.035849057,15,America/New_York,EDT,-14400000,-406.35,,,0.02,0.0001,0.0024,0.0058,25.81k,4.64k,,,,,,,,,,,,0.89%,,,,504.61%,"May 30, 2007","May 16, 2007",,,"Dec 30, 2015","Dec 30, 2014",-5.97%,-5.97%,-1.58%,-2.72%,770k,,,766k,,-46k,,,23k,0,25k,1.46,1.45,0.05,24k,66.25k,Value,94403,Healthcare,"Deltagen, Inc. provides drug discovery tools and services to the biopharmaceutical industry and to the academic research community in the United States. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was founded in 1997 and is headquartered in San Mateo, California.",San Mateo,650-345-7601,CA,1167523200,United States,http://www.deltagen.com,86400,1900 South Norfolk Street,Medical Instruments & Supplies,Suite 105
t-2,DGEN,1771000.0,0,,,55000,,55000,,215000,56000,56000,159000,,,,,0,234000,178000,19000,-1000,,55000,55000,230638000.0,252000.0,1771000.0,2023000.0,39000.0,-228408000.0,-498000.0,1586000.0,236000.0,252000.0,1586000.0,402000.0,26000.0,411000.0,149000.0,,246000.0,,-1000.0,,22000,-40000,-45000,-31000,-40000,-30000,-62000,159000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,0.0019,1629816724,0.0,0.0019,0.0019,0.0019,750,0.0019,0.0,0.0,0,0,finmb_27483,Other OTC,Deltagen Inc.,USD,25808,4637,0.0018000001,18.000002,1.0E-4 - 0.02,-0.018099999,-0.905,0.0001,0.02,1180569600,REGULAR,us_market,DELTAGEN INC,0,False,False,4,0.0,0.0019 - 0.0019,0.053,0.0024194445,-0.00051944447,-0.21469575,0.005757042,-0.0038570422,-0.66996944,3068652,0.035849057,15,America/New_York,EDT,-14400000,-406.35,,,0.02,0.0001,0.0024,0.0058,25.81k,4.64k,,,,,,,,,,,,0.89%,,,,504.61%,"May 30, 2007","May 16, 2007",,,"Dec 30, 2015","Dec 30, 2014",-5.97%,-5.97%,-1.58%,-2.72%,770k,,,766k,,-46k,,,23k,0,25k,1.46,1.45,0.05,24k,66.25k,Value,94403,Healthcare,"Deltagen, Inc. provides drug discovery tools and services to the biopharmaceutical industry and to the academic research community in the United States. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was founded in 1997 and is headquartered in San Mateo, California.",San Mateo,650-345-7601,CA,1167523200,United States,http://www.deltagen.com,86400,1900 South Norfolk Street,Medical Instruments & Supplies,Suite 105
t-3,DGEN,1716000.0,0,,,116000,,116000,,236000,116000,116000,120000,,,,,0,296000,180000,60000,0,,116000,116000,230638000.0,279000.0,1716000.0,1995000.0,39000.0,-228463000.0,-498000.0,1586000.0,267000.0,279000.0,1586000.0,402000.0,26000.0,383000.0,86000.0,,225000.0,,,-1000.0,-57000,-40000,-116000,182000,-40000,183000,240000,104000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,0.0019,1629816724,0.0,0.0019,0.0019,0.0019,750,0.0019,0.0,0.0,0,0,finmb_27483,Other OTC,Deltagen Inc.,USD,25808,4637,0.0018000001,18.000002,1.0E-4 - 0.02,-0.018099999,-0.905,0.0001,0.02,1180569600,REGULAR,us_market,DELTAGEN INC,0,False,False,4,0.0,0.0019 - 0.0019,0.053,0.0024194445,-0.00051944447,-0.21469575,0.005757042,-0.0038570422,-0.66996944,3068652,0.035849057,15,America/New_York,EDT,-14400000,-406.35,,,0.02,0.0001,0.0024,0.0058,25.81k,4.64k,,,,,,,,,,,,0.89%,,,,504.61%,"May 30, 2007","May 16, 2007",,,"Dec 30, 2015","Dec 30, 2014",-5.97%,-5.97%,-1.58%,-2.72%,770k,,,766k,,-46k,,,23k,0,25k,1.46,1.45,0.05,24k,66.25k,Value,94403,Healthcare,"Deltagen, Inc. provides drug discovery tools and services to the biopharmaceutical industry and to the academic research community in the United States. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was founded in 1997 and is headquartered in San Mateo, California.",San Mateo,650-345-7601,CA,1167523200,United States,http://www.deltagen.com,86400,1900 South Norfolk Street,Medical Instruments & Supplies,Suite 105
